Mikkel W. Pedersen

Sym004: A Novel Synergistic Anti–Epidermal Growth Factor Receptor Antibody Mixture with Superior Anticancer Efficacy

Mikkel W. Pedersen, Helle J. Jacobsen, Klaus Koefoed et al. · Cancer Research · 2010 · 227 citations

Pharmacy, Medicinal Chemistry, Oncology +17

EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes

Michael V. Grandal, Roza Zandi, Mikkel W. Pedersen et al. · Carcinogenesis · 2007 · 150 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses

Clara Montagut, Guillem Argilés, Fortunato Ciardiello et al. · JAMA Oncology · 2018 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

Activation of the EGFR Gene Target EphA2 Inhibits Epidermal Growth Factor–Induced Cancer Cell Motility

Alice Bjerregaard Larsen, Mikkel W. Pedersen, Marie‐Thérése Stockhausen et al. · Molecular Cancer Research · 2007 · 136 citations

Medicine, Cancer Biology, Oncology +17

Transcriptional gene expression profiling of small cell lung cancer cells.

Nina Marie Pedersen, Shila Mortensen, Susanne Berg Sørensen et al. · PubMed · 2003 · 108 citations

Life Sciences, Cell Biology, Molecular Biology +13